Prot#B17-166:(MYTHIC: MavYret for Transplanting kidneys with HepatItis C) A Phase 4, Multi-Center, Open-Label Study of Mavyret (Glecaprevir/Pibrentasvir) to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus

Project: Research project

Project Details

StatusActive
Effective start/end date6/4/196/4/22

Funding

  • Massachusetts General Hospital (Prot#B17-166)
  • AbbVie Inc. (Prot#B17-166)